Literature DB >> 7942991

High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression.

R J Hagerman1, C E Hull, J F Safanda, I Carpenter, L W Staley, R A O'Connor, C Seydel, M M Mazzocco, K Snow, S N Thibodeau.   

Abstract

Fragile X (fra(X)) males with a standardized IQ score of 70 or higher represent a high functioning (HF) or nonretarded fra(X) male group. This group, which does not include nonpenetrant males, has received little research attention to date. Of 221 fra(X) males who had been evaluated through The Children's Hospital in Denver since 1981 and had completed cognitive or developmental testing, 29 (13%) were high functioning by the above definition. We found that HF males on the whole had a lower cytogenetic score and were younger than retarded fra(X) males, but there was no difference between these two groups in the number of typical fra(X) physical manifestations present. FMR-1 DNA testing was performed on 134 fra(X) males and methylation status was determined for 51 of these. A greater percentage of HF males had a mosaic pattern or an incompletely methylated full mutation than did retarded males. A unique DNA pattern, an unmethylated fully expanded mutation, was discovered in 3 of the highest functioning fra(X) males. Protein studies performed on 2 of these males demonstrated the presence of FMR-1 protein, albeit at lower levels than normal. FMR-1 protein was not present in retarded fra(X) males. Significant FMR-1 protein expression may be responsible for higher cognitive functioning in the 2 males with unmethylated fully expanded mutations compared to retarded fra(X) males.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7942991     DOI: 10.1002/ajmg.1320510404

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  68 in total

Review 1.  Advanced technologies for the molecular diagnosis of fragile X syndrome.

Authors:  Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2015-10-21       Impact factor: 5.225

2.  A dual-mode single-molecule fluorescence assay for the detection of expanded CGG repeats in Fragile X syndrome.

Authors:  Brian Cannon; Cynthia Pan; Liangjing Chen; Andrew G Hadd; Rick Russell
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

3.  iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth.

Authors:  Matthew E Doers; Michael T Musser; Robert Nichol; Erich R Berndt; Mei Baker; Timothy M Gomez; Su-Chun Zhang; Leonard Abbeduto; Anita Bhattacharyya
Journal:  Stem Cells Dev       Date:  2014-04-30       Impact factor: 3.272

4.  FMR1 fully expanded mutation with minimal methylation in a high functioning fragile X male.

Authors:  Z Wang; A K Taylor; J A Bridge
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

5.  Don't miss patients with atypical FMR1 mutations: dysmorphism and clinical features in a boy with a partially methylated FMR1 full mutation.

Authors:  Edda Haberlandt; Sibylle Zotter; Martina Witsch-Baumgartner; Johannes Zschocke; Dieter Kotzot
Journal:  Eur J Pediatr       Date:  2014-07-17       Impact factor: 3.183

Review 6.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

7.  Trajectories and predictors of the development of very young boys with fragile X syndrome.

Authors:  Jane E Roberts; Jean B Mankowski; John Sideris; Barbara Davis Goldman; Deborah D Hatton; Penny L Mirrett; Grace T Baranek; J Steven Reznick; Anna C J Long; Donald B Bailey
Journal:  J Pediatr Psychol       Date:  2008-12-12

Review 8.  Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy.

Authors:  John A Tsiouris; W Ted Brown
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.

Authors:  Elaine Y Liu; Jenny Russ; Kathryn Wu; Donald Neal; Eunran Suh; Anna G McNally; David J Irwin; Vivianna M Van Deerlin; Edward B Lee
Journal:  Acta Neuropathol       Date:  2014-05-08       Impact factor: 17.088

10.  Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation.

Authors:  R Nick Hernandez; Rachel L Feinberg; Rebecca Vaurio; Natalie M Passanante; Richard E Thompson; Walter E Kaufmann
Journal:  Am J Med Genet A       Date:  2009-06       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.